The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Mode of action of agomelatine: Synergy between melatonergic and 5-HT2Creceptors
Abstract
OBJECTIVES: The association between depression and circadian rhythm disturbances is well established and successful treatment of depressed patients is accompanied by restoration of circadian rhythms. The new antidepressant agomelatine is an agonist of melatonergic MT₁/MT₂ receptors as well as an antagonist of serotonergic 5-HT2C receptors. Animal studies showed that agomelatine resynchronizes disturbed circadian rhythms and reduces depression-like behaviour. METHODS: This review analyzes results from different experimental studies. RESULTS: Recent data on the effects of agomelatine on cellular processes involved in antidepressant mechanisms have shown that the drug is able to increase the expression of brain-derived neurotrophic factor in prefrontal cortex and hippocampus, as well as the expression of activity-regulated cytoskeleton associated protein (Arc) in the prefrontal cortex. In line with this, prolonged treatment with agomelatine increases neurogenesis within the hippocampus, particularly via enhancement of neuronal cell survival. Agomelatine attenuates stress-induced glutamate release in the prefrontal/frontal cortex. Treatment with 5-HT2C antagonists or melatonin alone failed to reproduce these effects. CONCLUSIONS: The unique mode of action of agomelatine may improve the management of major depression by counteracting the pathogenesis of depression at cellular level, thereby relieving the symptoms of depression. These effects are suggested to be due to a synergistic action on MT₁/MT₂ and 5-HT2C receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coordination of circadian timing in mammals
Reppert, S. M., & Weaver, D. R. (2002) · Nature · doi:10.1038/nature00965 · Cited by 4,379
The genetics of mammalian circadian order and disorder: implications for physiology and disease
Takahashi, J. S., Hong, H.-K., Ko, C. H., & McDearmon, E. L. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2430 · Cited by 1,611 · cited 2×
“At their core, the clocks contain a cell autonomous oscillator generated by a transcription – translation negative-feedback loop with a crucial delay between stimulus and response that, in mammals, mainly involves the Clock, Bmal1, Per1, Per2, Cry1 and Cry2 genes (Figure 2) (Lowery and Takahashi 2004; Gallego and Virs…”
BackgroundCARLEZONJR, W., DUMAN, R., & NESTLER, E. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.005 · Cited by 1,346
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221
Lyford, G. L., Yamagata, K., Kaufmann, W. E., Barnes, C. A., Sanders, L. K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Lanahan, A. A., & Worley, P. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90299-6 · Cited by 1,212
A clockwork web: circadian timing in brain and periphery, in health and disease
Hastings, M. H., Reddy, A. B., & Maywood, E. S. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1177 · Cited by 1,195
BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis
Bramham, C. R., & Messaoudi, E. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.003 · Cited by 1,193
Posttranslational Mechanisms Regulate the Mammalian Circadian Clock
Lee, C., Etchegaray, J.-P., Cagampang, F. R. A., Loudon, A. S. I., & Reppert, S. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00610-9 · Cited by 1,160
Tsuno, N., Besset, A., & Ritchie, K. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1008 · Cited by 1,084
Guzowski, J. F., Lyford, G. L., Stevenson, G. D., Houston, F. P., McGaugh, J. L., Worley, P. F., & Barnes, C. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-03993.2000 · Cited by 992
Mammalian circadian biology: elucidating genome-wide levels of temporal organization
Lowrey, P. L., & Takahashi, J. S. (2004) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.5.061903.175925 · Cited by 976
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Post-translational modifications regulate the ticking of the circadian clock
Gallego, M., & Virshup, D. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2106 · Cited by 875
Melatonin—A pleiotropic, orchestrating regulator molecule
Hardeland, R., Cardinali, D. P., Srinivasan, V., Spence, D. W., Brown, G. M., & Pandi-Perumal, S. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.12.004 · Cited by 843
Ying, S.-W., Futter, M., Rosenblum, K., Webber, M. J., Hunt, S. P., Bliss, T. V. P., & Bramham, C. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01532.2002 · Cited by 784 · cited 2×
“2008), and it is regulated by BDNF modulation (Ying et al. 2002).”
BackgroundMelatonin Shifts Human Orcadian Rhythms According to a Phase-Response Curve
Lewy, A. J., Ahmed, S., Jackson, J. M. L., & Sack, R. L. (1992) · Chronobiology International · doi:10.3109/07420529209064550 · Cited by 693
Circadian rhythms in isolated brain regions
Abe, M., Herzog, E. D., Yamazaki, S., Straume, M., Tei, H., Sakaki, Y., Menaker, M., & Block, G. D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00350.2002 · Cited by 681
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
de Bodinat, C., Guardiola-Lemaitre, B., Mocaër, E., Renard, P., Muñoz, C., & Millan, M. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3140 · Cited by 593
NPAS2: an analog of clock operative in the mammalian forebrain
Reick, M., Garcia, J. A., Dudley, C., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1060699 · Cited by 572
Millan, M. J., Gobert, A., Lejeune, F., Dekeyne, A., Newman-Tancredi, A., Pasteau, V., Rivet, J.-M., & Cussac, D. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051797 · Cited by 516
The Suprachiasmatic Nucleus: A 25-Year Retrospective
Weaver, D. R. (1998) · Journal of Biological Rhythms · doi:10.1177/074873098128999952 · Cited by 508
Entrainment of free-running circadian rhythms by melatonin in blind people
Sack, R. L., Brandes, R. W., Kendall, A. R., & Lewy, A. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010123431503 · Cited by 490
The Immediate Early Gene Arc/Arg3.1: Regulation, Mechanisms, and Function
Bramham, C. R., Worley, P. F., Moore, M. J., & Guzowski, J. F. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3864-08.2008 · Cited by 484
Souêtre, E., Salvati, E., Belugou, J.-L., Pringuey, D., Candito, M., Krebs, B., Ardisson, J.-L., & Darcourt, G. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90207-2 · Cited by 396
Wolden-Hanson, T., Mitton, D. R., McCants, R. L., Yellon, S. M., Wilkinson, C. W., Matsumoto, A. M., & Rasmussen, D. D. (2000) · Endocrinology · doi:10.1210/endo.141.2.7311 · Cited by 390
Melatonin receptors in humans: biological role and clinical relevance
Ekmekcioglu, C. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.01.002 · Cited by 370
Cirelli, C., & Tononi, G. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09187.2000 · Cited by 369
The Role of CREB in Depression and Antidepressant Treatment
Blendy, J. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.003 · Cited by 365 · cited 1×
“Several works have shown that activation of relevant upstream signalling and CREB phosphorylation in hippocampus and cortical areas are a typical effect of most chronic antidepressants (Carlezon et al. 2005; Blendy 2006; Tardito et al. 2006, 2009).”
BackgroundDubocovich, M. L., Yun, K., Al‐Ghoul, W. M., Benloucif, S., & Masana, M. I. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1211 · Cited by 364
L??o, H., Hale, A., & D??haenen, H. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200209000-00004 · Cited by 361
Localization and characterization of melatonin receptors in rodent brain by in vitro autoradiography
Weaver, D., Rivkees, S., & Reppert, S. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-07-02581.1989 · Cited by 357
Biological rhythm disturbances in mood disorders
Wirz-Justice, A. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000195660.37267.cf · Cited by 354
Guilding, C., & Piggins, H. D. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05581.x · Cited by 348
Circadian oscillation of hippocampal MAPK activity and cAMP: implications for memory persistence
Eckel-Mahan, K. L., Phan, T., Han, S., Wang, H., Chan, G. C.-K., Scheiner, Z. S., & Storm, D. R. (2008) · Nature Neuroscience · doi:10.1038/nn.2174 · Cited by 347
Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis
Banasr, M., Soumier, A., Hery, M., Mocaër, E., & Daszuta, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.025 · Cited by 318 · cited 1×
“It was demonstrated that chronic treatment with agomelatine enhances cell proliferation, maturation, and survival in hippocampus (Banasr et al. 2006; Soumier et al. 2009).”
BackgroundTardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.7 · Cited by 303 · cited 2×
“Among the others, the neurotrophin brainderived neurotrophic factor (BDNF), is thought to play a key role in the etiology of mood disorders as well as in the neuroplastic mechanisms associated with antidepressant treatment (Tardito et al. 2006; Martinowich et al. 2007; Calabrese et al. 2009).”
BackgroundSelf-citationNeuronal plasticity: A link between stress and mood disorders
Calabrese, F., Molteni, R., Racagni, G., & Riva, M. A. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.014 · Cited by 301
Self-citationMusazzi, L., Milanese, M., Farisello, P., Zappettini, S., Tardito, D., Barbiero, V. S., Bonifacino, T., Mallei, A., Baldelli, P., Racagni, G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008566 · Cited by 289
Self-citationMillan, M. J. (2005) · Therapies · doi:10.2515/therapie:2005065 · Cited by 283
Effect of Agomelatine in the Chronic Mild Stress Model of Depression in the Rat
Papp, M., Gruca, P., Boyer, P.-A., & Mocaër, E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300091 · Cited by 268
Kasper, S., Hajak, G., Wulff, K., Hoogendijk, W. J. G., Montejo, A. L., Smeraldi, E., Rybakowski, J. K., Quera-Salva, M.-A., Wirz-Justice, A. M., Picarel-Blanchot, F., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05347blu · Cited by 257
Circadian misalignment in major depressive disorder
Emens, J., Lewy, A., Kinzie, J. M., Arntz, D., & Rough, J. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2009.04.009 · Cited by 253
New selective ligands of human cloned melatonin MT1 and MT2 receptors
Audinot, V., Mailliet, F., Lahaye-Brasseur, C., Bonnaud, A., Le Gall, A., Amossé, C., Dromaint, S., Rodriguez, M., Nagel, N., Galizzi, J.-P., et al. (2003) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-003-0751-2 · Cited by 248
Millan, M. J., Brocco, M., Gobert, A., & Dekeyne, A. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1962-z · Cited by 248
Arc/Arg3.1: Linking Gene Expression to Synaptic Plasticity and Memory
Tzingounis, A. V., & Nicoll, R. A. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.016 · Cited by 245
Efficacy of Melatonin Treatment in Jet Lag, Shift Work, and Blindness
Arendt, J., Skene, D. J., Middleton, B., Lockley, S. W., & Deacon, S. (1997) · Journal of Biological Rhythms · doi:10.1177/074873049701200616 · Cited by 239
Bonanno, G., Giambelli, R., Raiteri, L., Tiraboschi, E., Zappettini, S., Musazzi, L., Raiteri, M., Racagni, G., & Popoli, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5033-04.2005 · Cited by 234
Self-citationBourin, M., Mocaër, E., & Porsolt, R. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0414 · Cited by 226
Di Giovanni, G., De Deurwaerdére, P., Di Mascio, M., Di Matteo, V, Esposito, E., & Spampinato, U. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00655-1 · Cited by 218
Wang, L. M. C., Dragich, J. M., Kudo, T., Odom, I. H., Welsh, D. K., O'Dell, T. J., & Colwell, C. S. (2009) · ASN Neuro · doi:10.1042/an20090020 · Cited by 199
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor
Pälvimäki, E. P., Majasuo, H., Laakso, A., Kuoppamäki, M., Syvälahti, E., Roth, B. L., & Hietala, J. (1996) · Psychopharmacology · doi:10.1007/bf02246453 · Cited by 197
Mantovani, M., Pértile, R., Calixto, J. B., Santos, A. R. S., & Rodrigues, A. L. S. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00306-9 · Cited by 197
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.9.1133 · Cited by 189
Hasler, B. P., Buysse, D. J., Kupfer, D. J., & Germain, A. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.04.027 · Cited by 177
Contributions of 5-HT2C receptors to multiple actions of central serotonin systems
Giorgetti, M., & Tecott, L. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.036 · Cited by 173
Luo, A. H., & Aston‐Jones, G. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06606.x · Cited by 172
Soumier, A., Banasr, M., Lortet, S., Masmejean, F., Bernard, N., Kerkerian-Le-Goff, L., Gabriel, C., Millan, M. J., Mocaer, E., & Daszuta, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.72 · Cited by 171
Major depressive disorder, sleep EEG and agomelatine: an open-label study
Salva, M.-A. Q., Vanier, B., Laredo, J., Hartley, S., Chapotot, F., Moulin, C., Lofaso, F., & Guilleminault, C. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007754 · Cited by 170
Melatonin for the Treatment of Sleep Disturbances in Major Depressive Disorder
Dolberg, O. T., Hirschmann, S., & Grunhaus, L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.8.1119 · Cited by 169
The NGF saga: From animal models of psychosocial stress to stress-related psychopathology
Cirulli, F., & Alleva, E. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.002 · Cited by 162
Agomelatine in the Treatment of Major Depressive Disorder: Potential for Clinical Effectiveness
Kennedy, S. H., & Rizvi, S. J. (2010) · CNS Drugs · doi:10.2165/11534420-000000000-00000 · Cited by 160
Sleep disturbances and depression: a challenge for antidepressants
Lam, R. W. M. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000195658.91524.61 · Cited by 158
Morley‐Fletcher, S., Mairesse, J., Soumier, A., Banasr, M., Fagioli, F., Gabriel, C., Mocaër, E., Daszuta, A., McEwen, B. S., Nicoletti, F., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2280-x · Cited by 150
The regulation of central and peripheral circadian clocks in humans
Cermakian, N., & Boivin, D. B. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00660.x · Cited by 141
Pandi-Perumal, S. R., Moscovitch, A., Srinivasan, V., Spence, D. W., Cardinali, D. P., & Brown, G. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.007 · Cited by 139
Dekeyne, A., la Cour, C. M., Gobert, A., Brocco, M., Lejeune, F., Serres, F., Sharp, T., Daszuta, A., Soumier, A., Papp, M., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1177-9 · Cited by 135
Cell “circadian” cycle: New role for mammalian core clock genes
Borgs, L., Beukelaers, P., Vandenbosch, R., Belachew, S. M., Nguyen, L., & Malgrange, B. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7869 · Cited by 133
Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS)
Armstrong, S. M., McNulty, O. M., Lemaître, B. J., & Redman, J. R. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90315-k · Cited by 129
Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model
Bertaina‐Anglade, V., Rochelle, C. D. L., Boyer, P., & Mocaër, E. (2006) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3280116e5c · Cited by 128
Deery, M. J., Maywood, E. S., Chesham, J. E., Sládek, M., Karp, N. A., Green, E. W., Charles, P. D., Reddy, A. B., Kyriacou, C. P., Lilley, K. S., et al. (2009) · Current Biology · doi:10.1016/j.cub.2009.10.024 · Cited by 125 · cited 2×
“This, most likely, depends upon circadian expression of intracellular proteins, including rate-limiting factors in metabolism, transport proteins, and proteins involved with synaptic vesicle cycling (Weaver 1998; Deery et al. 2009).”
BackgroundWeil, Z. M., Hotchkiss, A. K., Gatien, M. L., Pieke-Dahl, S., & Nelson, R. J. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.09.016 · Cited by 125
Melatonin and the Metabolic Syndrome: Physiopathologic and Therapeutical Implications
Cardinali, D. P., Cano, P., Jiménez‐Ortega, V., & Esquifino, A. I. (2011) · Neuroendocrinology · doi:10.1159/000324699 · Cited by 124
Païzanis, E., Renoir, T., Lelievre, V., Saurini, F., Melfort, M., Gabriel, C., Barden, N., Mocaër, E., Hamon, M., & Lanfumey, L. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990514 · Cited by 123
Holmes, M. C., French, K. L., & Seckl, J. R. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(94)00207-u · Cited by 120
A direct retinal projection to the dorsal raphe nucleus in the rat
Shen, H., & Semba, K. (1994) · Brain Research · doi:10.1016/0006-8993(94)91435-4 · Cited by 114
Redman, J., Brown, M., Lemaître, B. J., Delagrange, P., & Armstrong, S. M. (1995) · Psychopharmacology · doi:10.1007/bf02245938 · Cited by 113
Masana, M. I., Benloucif, S., & Dubocovich, M. L. (2000) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.280309.x · Cited by 110
Holmes, M. C., French, K. L., & Seckl, J. R. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04056.1997 · Cited by 108
Brain Clocks: From the Suprachiasmatic Nuclei to a Cerebral Network
Mendoza, J., & Challet, É. (2009) · The Neuroscientist · doi:10.1177/1073858408327808 · Cited by 105
Martinet, L., Lemaître, B. J., & Mocaër, E. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02221-x · Cited by 104
Zhu, L., Liu, D., Hu, J., Cheng, J. Q., Wang, S., Wang, Q., Wang, F., Chen, J., & Wang, J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5223-09.2010 · Cited by 103
Michael-Titus, A. T., Bains, S., Jeetle, J. K., & Whelpton, R. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00390-0 · Cited by 103
The pharmacological properties of antidepressants
Racagni, G., & Popoli, M. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283311acd · Cited by 102
Self-citationRetinal afferents to the dorsal raphe nucleus in rats and Mongolian gerbils
Fite, K. V., onis, S. J., Foote, W. E., & Bengston, L. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19991129)414:4<469::aid-cne4>3.0.co;2-p · Cited by 98
Reeth, O. V., Weibel, L., Olivares, E., Maccari, S., Mocaër, E., & Turek, F. W. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.5.r1582 · Cited by 93
Is there a direct retina-raphe-suprachiasmatic nucleus pathway in the rat?
Kawano, H., Decker, K., & Reuss, S. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12795-6 · Cited by 89
Depression: A Disorder of Timekeeping?
Cauter, E. V., & Turek, F. W. (1986) · Perspectives in biology and medicine · doi:10.1353/pbm.1986.0033 · Cited by 85
Central Serotonin2C Receptor: From Physiology to Pathology
Giovanni, G. D., Matteo, V. D., Pierucci, M., Benigno, A., & Esposito, E. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606778522113 · Cited by 85
Molteni, R., Calabrese, F., Pisoni, S., Gabriel, C., Mocaër, E., Racagni, G., & Riva, M. A. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903447659 · Cited by 78
Self-citationRedman, J. R., & Francis, A. J. P. (1998) · Journal of Biological Rhythms · doi:10.1177/074873098128999907 · Cited by 74
Comparative effects of a melatonin agonist on the circadian system in mice and Syrian hamsters
Reeth, O. V., Olivares, E., Zhang, Y., Zee, P. C., Mocaër, E., Defrance, R., & Turek, F. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00382-x · Cited by 71
Neuroendocrine profiles in mood disorders
Linkowski, P. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003407 · Cited by 70
Calabrese, F., Molteni, R., Gabriel, C., Mocaër, E., Racagni, G., & Riva, M. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2129-8 · Cited by 69
Self-citationEffects of melatonin receptor ligands on swim test immobility
Overstreet, D. H., Puciłowski, O., Retton, M.-C., Delagrange, P., & Lemaître, B. J. (1998) · Neuroreport · doi:10.1097/00001756-199801260-00014 · Cited by 67
Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex
Tokarski, K., Bobula, B., Wabno, J., & Hess, G. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.007 · Cited by 65
Serotonin receptor ligands and the treatment of obesity.
Vickers, S. P., & Dourish, C. T. (2004) · PubMed · Cited by 64
Tardito, D., Milanese, M., Bonifacino, T., Musazzi, L., Grilli, M., Mallei, A., Mocaër, E., Gabriel, C., Racagni, G., Popoli, M., et al. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-68 · Cited by 61
Self-citationChagraoui, A., Protais, P., Filloux, T., & Mocaër, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1465-3 · Cited by 60
Immunohistochemical localization of serotonin receptors in the rat suprachiasmatic nucleus
Moyer, R. W., & Kennaway, D. J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00536-4 · Cited by 59
Grassi-Zucconi, G., Semprevivo, M., Mocaër, E., Kristensson, K., & Bentivoglio, M. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02032-2 · Cited by 50
Early induction of CREB activation and CREB-regulating signalling by antidepressants
Tardito, D., Musazzi, L., Tiraboschi, E., Mallei, A., Racagni, G., & Popoli, M. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000376 · Cited by 46
Self-citationKennaway, D. J., Moyer, R. W., Voultsios, A., & Varcoe, T. J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02091-1 · Cited by 44
Psychotropic effects of ritanserin, a selective S2 antagonist: an open study
Strauß, W. H., & Klieser, E. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90710-c · Cited by 38
The Circadian System and Melatonin: Lessons from Rats and Mice
Korf, H., von Gall, C., & Stehle, J. H. (2003) · Chronobiology International · doi:10.1081/cbi-120022415 · Cited by 37
Melatonin as a Therapeutic Agent in the Treatment of Sleep Disturbance in Depression
deVries, M. W., & Peeters, F. P. M. L. (1997) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199703000-00010 · Cited by 37
Katoh‐Semba, R., Tsuzuki, M., Miyazaki, N., Matsuda, M., Nakagawa, C. W., Ichisaka, S., Sudo, K., Kitajima, S., Hamatake, M., Hata, Y., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05565.x · Cited by 30
The neurobiology of circadian rhythms
van der Zee, E. A., Boersma, G. J., & Hut, R. A. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283319b29 · Cited by 23
Corbach‐Söhle, S., Schmelting, B., Fuchs, E., & Mocaër, E. (2007) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(07)70534-5 · Cited by 9
Linnik, I. G., McKie, S., Stark, J., et al. (2009) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(09)70374-8 · Cited by 5
Cited by
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
Liu, J., Clough, S. J., Hutchinson, A. J., Adamah-Biassi, E. B., Popovska-Gorevski, M., & Dubocovich, M. L. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124742 · Cited by 630
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
Update on melatonin receptors: IUPHAR Review 20
Jockers, R., Delagrange, P., Dubocovich, M. L., Markus, R. P., Renault, N., Tosini, G., Cecon, E., & Zlotos, D. P. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13536 · Cited by 422
Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
Taylor, D., Sparshatt, A., Varma, S., & Olofinjana, O. (2014) · BMJ · doi:10.1136/bmj.g1888 · Cited by 334
Guardiola‐Lemaitre, B., De Bodinat, C., Delagrange, P., Millan, M. J., Munoz, C., & Mocaër, E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12720 · Cited by 182
Metadata
- Authors
- Racagni, G., Riva, M. A., Molteni, R., Musazzi, L., Calabrese, F., Popoli, M., & Tardito, D.
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2011-10-14
- Volume
- 12
- Issue
- 8
- Pages
- 574-587
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2101832118
- Cited by
- 282
- References
- 109
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.